TRI

TRI provides AI-driven risk-based quality management (RBQM) solutions for clinical trials, helping sponsors, contract research organizations, medical monitors and trial managers strengthen study oversight. Its platform turns data from clinical trial systems into prioritized signals and actions, helping teams identify emerging risks earlier, make informed decisions and maintain a traceable record of oversight.

TRI’s offerings include OPRA Centralized Monitoring for reviewing critical signals across sites, OPRA Risk Assessment & Management for defining and tracking risks, controls and quality objectives, and OPRA Subject Monitoring for reviewing subject-level timelines with audit trails and role-based access. TRIAL.OS adds an AI layer that can draft protocol-linked quality objectives, risks and controls, and guide teams toward ranked, explained next steps. The platform is designed to work above existing systems.

TRI also offers TRIAL.OS e-learning, complimentary training and resources such as guides, webinars and whitepapers. Its services support a connected workflow to plan, detect and review risk, with the goal of more focused monitoring and inspection-ready evidence.